Bharat Book Bureau

Archives for Oncology

Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a… » read more

Posted by bharatbook

The Cervical Cancer Partnering 2007-2012 report provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies. * Trends in cervical cancer partnering deals * Top cervical cancer deals by value * Deals listed by company A-Z, industry sector, stage of development, technology type http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/cervical-cancer-partnering-2007-2012.html Description… » read more

Posted by bharatbook

The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. * Trends in oncology partnering deals * Average deal terms for headline, upfront and royalty by stage of development * Oncology partnering agreement structure * Oncology partnering… » read more

Posted by bharatbook

The symbiotic relationship between key opinion leaders (KOLs) and the pharmaceutical industry is dynamic and ever-changing. But while the industry knows what it wants from KOLs, what do KOLs need from the industry? http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/interacting-with-oncology-kols-fulfilling-unmet-needs.html In a fascinating new premium series, FirstWord digs into the mindset of leading KOLs from around the world to offer the… » read more

Posted by bharatbook

Bharatbook added a new Database “Bristol-Myers Squibb Co.: PharmaVitae Profile” provides data in PDF format and Slid Pack Format which had an information on Picking out key opportunities and threats and evaluating the company’s prescription pharmaceuticals outlook. This analysis examines the historical and forecast performance for Bristol-Myers Squibb in the prescription pharmaceutical sector. The profile… » read more

Posted by bharatbook

Lung cancer is the most common type of cancer across the globe. According to WHO, lung cancer is expected to be more prominent in the underdeveloped world due to an increase in the use of tobacco products; tobacco is the primary cause of around 80% of all lung cancers. Global incidence of lung cancer was… » read more

Posted by bharatbook

Inhibitors of Raf and MEK (MAPK/ERK kinase) have gained great interest because they suppress growth of tumors with mutant B-Raf and some with mutant Ras which depend upon ERK signaling for proliferation. The selectivity of mutant B-Raf inhibitors lead to a broader therapeutic index and may explain the greater antitumor activity observed with mutant B-Raf… » read more

Posted by bharatbook